Light-stabilized pharmaceutical composition and its preparation method and pharmaceutical use

A composition and drug technology, applied in the field of medicine, can solve problems such as easy decomposition

Active Publication Date: 2022-05-13
HUNAN DONGTING PHARMA
View PDF8 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0011] In addition, it is known that lorazepam is sensitive to light and is easily decomposed when exposed to light, so its raw materials and preparations such as tablets usually need to be stored away from light

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Light-stabilized pharmaceutical composition and its preparation method and pharmaceutical use
  • Light-stabilized pharmaceutical composition and its preparation method and pharmaceutical use
  • Light-stabilized pharmaceutical composition and its preparation method and pharmaceutical use

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0109] Embodiment 1: Preparation of lorazepam

[0110] Step 1, acetoxylation reaction prepares the acetoxy compound of formula II

[0111] Add 1 mol (305 g) of the ketone base of formula I, 14 mol of glacial acetic acid, 2.5 mol of potassium acetate, 1.8 mol of potassium persulfate, and 2.5 mol of iodine into the reaction flask, stir at 80°C to react for 7 hours, then distill under reduced pressure at 65°C Remove the acid solution; then add ethyl acetate (4 times the amount of the ketone base), 5% sodium thiosulfate solution (6 times the amount of the ketone base) in the reaction flask, stir for 25 minutes, let stand layer; collect the organic layer, extract the aqueous layer twice with ethyl acetate, combine the organic layers, add 1.25 times the volume of saturated sodium chloride solution therein, stir for 25 minutes, let stand to separate the layers, and separate the organic layer; the organic layer Add medicinal charcoal (0.75%), stir and decolorize at 65°C for 25 minu...

Embodiment 2

[0116] Embodiment 2: Preparation of lorazepam

[0117] Step 1, acetoxylation reaction prepares the acetoxy compound of formula II

[0118]Add 1 mol (305 g) of ketones of formula I, 15 mol of glacial acetic acid, 2 mol of potassium acetate, 2 mol of potassium persulfate, and 2 mol of iodine into the reaction flask, stir at 70°C to react for 8 hours, then distill off the acid solution at 70°C under reduced pressure Then add ethyl acetate (3 times of the ketone-based charging capacity), 5% sodium thiosulfate solution (7 times of the ketone-based charging capacity) in the reaction flask, stir for 20 minutes, leave standstill and make layering; collect Extract the organic layer and the aqueous layer twice with ethyl acetate, combine the organic layers, add 1 times the volume of saturated sodium chloride solution to it, stir for 20 minutes, let stand to separate the layers, and separate the organic layer; the organic layer is used for medicinal purposes Charcoal (0.5%), stirred a...

Embodiment 3

[0123] Embodiment 3: Preparation of lorazepam

[0124] Step 1, acetoxylation reaction prepares the acetoxy compound of formula II

[0125] Add 1 mol (305 g) of ketones of formula I to the reaction flask, 12 mol of glacial acetic acid, 3 mol of potassium acetate, 1.5 mol of potassium persulfate, and 3 mol of iodine, stir at 90°C to react for 6 hours, then distill off the acid at 60°C under reduced pressure solution; then add ethyl acetate (5 times of the ketone-based feeding amount), 5% sodium thiosulfate solution (5 times of the ketone-based feeding amount) in the reaction flask, stir for 30 minutes, and let stand to make stratification; Collect the organic layer, extract the aqueous layer twice with ethyl acetate, combine the organic layers, add 1.5 times the volume of saturated sodium chloride solution to it, stir for 30 minutes, let stand to separate the layers, and separate the organic layer; add medicine to the organic layer Use charcoal (1%), stir and decolorize at 60...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
melting pointaaaaaaaaaa
melting pointaaaaaaaaaa
melting pointaaaaaaaaaa
Login to view more

Abstract

The invention relates to a light-stabilized pharmaceutical composition, a preparation method and a pharmaceutical use thereof. Specifically, the pharmaceutical composition provided by the present invention comprises lorazepam crystals and pharmaceutical excipients; said lorazepam crystals use Cu-Kα radiation, and in the powder X-ray diffraction spectrum represented by 2θ angle, in There are diffraction peaks at about 12.17°, about 14.15°, about 15.27°, about 16.84°, about 17.91°, and about 20.81°; There are diffraction peaks at 15.27°, about 16.84°, about 17.91°, about 20.81°, about 21.44°, and about 26.38°. The invention also provides a preparation method of the pharmaceutical composition. Pharmaceutical uses of the pharmaceutical composition are also provided. The new crystal form of lorazepam and the pharmaceutical composition prepared by the method of the present invention exhibit such excellent properties as described in the description of the present invention.

Description

technical field [0001] The invention belongs to the technical field of medicine, and relates to a preparation method of benzodiazepine drug lorazepam. It also relates to lorazepam prepared by the method, and its use in drugs with anxiolytic, antiepileptic, anticonvulsant and sedative hypnotic effects. The lorazepam of the present invention presents a new crystal form. Furthermore, the present invention also relates to a light-stabilized lorazepam pharmaceutical composition and its preparation method and pharmaceutical application. Background technique [0002] Loarzepam, molecular formula C15H10Cl2N2O2, molecular weight 321.16, chemical name: 7-chloro-5-(2-chlorophenyl)-1,3-dihydro-3-hydroxy-2H-1,4-benzo Diazepin-2-one, its chemical structural formula is: [0003] [0004] Lorazepam is white or off-white crystalline powder; odorless; lorazepam is slightly soluble in ethanol and almost insoluble in water. [0005] Lorazepam, also known as lorazepam, lorazepam and loraz...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/5513C07D243/26C07D243/24A61P25/22A61P25/08A61P25/20
CPCA61K31/5513C07D243/26C07D243/24A61P25/22A61P25/08A61P25/20C07B2200/13
Inventor 王波侯奇伟冯建辉
Owner HUNAN DONGTING PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap